Rosenblum MD, Remedios KA, Abbas AK (2015) Mechanisms of human autoimmunity. J Clin Invest 125(6):2228–2233
Kleinewietfeld M, Hafler DA (2013) The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 25(4):305–312
Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38(2–3):J156–J169
Marson A, Housley WJ, Hafler DA (2015) Genetic basis of autoimmunity. J Clin Invest 125(6):2234–2241
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M (2014) Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep 14(1):404
Organization WH, Federation MSI (2008) Atlas: multiple sclerosis resources in the world 2008. Cited 2016 Jan 20. http://www.who.int/iris/handle/10665/43968
Bach J-F (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347(12):911–920
Houzen H, Niino M, Hata D, Nakano F, Kikuchi S, Fukazawa T et al (2008) Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler Houndmills Basingstoke Engl 14(7):887–892
Fleming J, Fabry Z (2007) The hygiene hypothesis and multiple sclerosis. Ann Neurol 61(2):85–89
Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3(12):709–718
Thorburn AN, Macia L, Mackay CR (2014) Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40(6):833–842
Odegaard AO, Koh WP, Yuan J-M, Gross MD, Pereira MA (2012) Western-style fast food intake and cardiometabolic risk in an Eastern country. Circulation 126(2):182–188
Conlon MA, Bird AR (2015) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7(1):17–44
Kuhn KA, Stappenbeck TS (2013) Peripheral education of the immune system by the colonic microbiota. Semin Immunol 25(5):364–369
Salonen A, de Vos WM (2014) Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol 5:239–262
Atlas-of-MS.pdf [Internet]. Cited 2016 Feb 9. http://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf
Haghikia A, Hohlfeld R, Gold R, Fugger L (2013) Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 19(5):309–319
Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2015) The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets. Lancet Neurol
Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2015) The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol
Lande R, Gafa V, Serafini B, Giacomini E, Visconti A, Remoli ME et al (2008) Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J Neuropathol Exp Neurol 67(5):388–401
Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL et al (2006) Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 65(2):124–141
Jack C, Ruffini F, Bar-Or A, Antel JP (2005) Microglia and multiple sclerosis. J Neurosci Res 81(3):363–373
Zindler E, Zipp F (2010) Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol 24(4):551–562
Molnarfi N, Schulze-Topphoff U, Weber MS, Patarroyo JC, Prod’homme T, Varrin-Doyer M et al (2013) MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med 210(13):2921–2937
Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8(11):613–623
Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV (2012) The evidence for a role of B cells in multiple sclerosis. Neurology 78(11):823–832
Degn M, Modvig S, Dyring-Andersen B, Bonefeld CM, Frederiksen JL, Geisler C et al (2015) Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis. Mult Scler Houndmills Basingstoke Engl
Schirmer L, Rothhammer V, Hemmer B, Korn T (2013) Enriched CD161high CCR6 + γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis. JAMA Neurol 70(3):345–351
Rodríguez-Martín E, Picón C, Costa-Frossard L, Alenda R, Sainz de la Maza S, Roldán E et al (2015) Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 180(2):243–249
Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y et al (2014) Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343(6178):1249288
Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517(7534):293–301
Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G et al (2013) Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13(2):145–149
Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain J Neurol 129(Pt 8):1953–1971
Steinman L, Zamvil SS (2005) Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 26(11):565–571
Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60(1):12–21
Stromnes IM, Goverman JM (2006) Active induction of experimental allergic encephalomyelitis. Nat Protoc 1(4):1810–1819
Stromnes IM, Goverman JM (2006) Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1(4):1952–1960
Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415(6871):536–541
Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744–748
Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198(12):1951–1957
Huber S, Gagliani N, Flavell RA (2012) Life, death, and miracles: Th17 cells in the intestine. Eur J Immunol 42(9):2238–2245
Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517
Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S et al (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol Baltim Md 1950 177(1):566–73
Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B et al (2009) IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 119(1):61–69
El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F et al (2011) The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12(6):568–575
Codarri L, Gyülvészi G, Tosevski V, Hesske L, Fontana A, Magnenat L et al (2011) RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12(6):560–567
Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM et al (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172(1):146–155
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173–1175
Darlington PJ, Touil T, Doucet J-S, Gaucher D, Zeidan J, Gauchat D et al (2013) Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol 73(3):341–354
Kleinewietfeld M, Hafler DA (2014) Regulatory T cells in autoimmune neuroinflammation. Immunol Rev 259(1):231–244
Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10(9):1000–1007
Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT (2004) Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 5(11):1149–1156
Xu L, Kitani A, Fuss I, Strober W (2007) Cutting edge: regulatory T cells induce CD4+ CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol Baltim Md 1950 178(11):6725–9
Koenen HJPM, Smeets RL, Vink PM, van Rijssen E, Boots AMH, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112(6):2340–2352
Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G et al (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38(12):3274–3281
Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP et al (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29(1):44–56
Dominguez-Villar M, Baecher-Allan CM, Hafler DA (2011) Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med 17(6):673–675
Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens J-L et al (2008) Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123(1):79–89
Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199(7):971–979
Frisullo G, Nociti V, Iorio R, Patanella AK, Caggiula M, Marti A et al (2009) Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients. Immunology 127(3):418–428
Hawkes CH, Macgregor AJ (2009) Twin studies and the heritability of MS: a conclusion. Mult Scler 15(6):661–667
International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CCA et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214–9
Nylander A, Hafler DA (2012) Multiple sclerosis. J Clin Invest 122(4):1180–1188
The International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357(9):851–862
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838
Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH et al (2014) Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 71(3):306–314
Holick MF (2005) Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98(10):1024–1027
Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG et al (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa women’s health study. Arthritis Rheum 50(1):72–77
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83(4):754–759
Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol Baltim Md 1950 167(4):1945–53
Breuer J, Schwab N, Schneider-Hohendorf T, Marziniak M, Mohan H, Bhatia U et al (2014) Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol 75(5):739–758
Bäärnhielm M, Olsson T, Alfredsson L (2014) Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 20(6):726–732
Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H et al (2012) ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 69(8):1044–1051
Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D et al (2015) High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 4(2):159–169
Simon KC, Munger KL, Ascherio A (2012) Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics. Curr Opin Neurol 25(3):246–251
Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9(6):599–612
Okada H, Kuhn C, Feillet H, Bach J-F (2010) The, “hygiene hypothesis” for autoimmune and allergic diseases: an update. Clin Exp Immunol 160(1):1–9
Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288–299
Lünemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Münz C et al (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain J Neurol 129(Pt 6):1493–1506
Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B et al (2010) Absence of Epstein–Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74(14):1127–1135
Versini M, Jeandel P-Y, Bashi T, Bizzaro G, Blank M, Shoenfeld Y (2015) Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med 13:81
Ben-Ami Shor D, Harel M, Eliakim R, Shoenfeld Y (2013) The hygiene theory harnessing helminths and their ova to treat autoimmunity. Clin Rev Allergy Immunol 45(2):211–6
La Flamme AC, Ruddenklau K, Bäckström BT (2003) Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 71(9):4996–5004
Gruden-Movsesijan A, Ilic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Milic M, Sofronic-Milosavljevic L (2010) Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunol 32(6):450–459
Kuijk LM, Klaver EJ, Kooij G, van der Pol SMA, Heijnen P, Bruijns SCM et al (2012) Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol 51(2):210–218
Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD et al (2011) Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler Houndmills Basingstoke Engl 17(6):743–754
Weinstock JV, Summers R, Elliott DE (2004) Helminths and harmony. Gut 53(1):7–9
Neish AS (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136(1):65–80
Fanaro S, Chierici R, Guerrini P, Vigi V (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Oslo Nor 1992 Suppl 91(441):48–55
Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I et al (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2):511–521
Marcobal A, Sonnenburg JL (2012) Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18(Suppl 4):12–15
Louis P, O’Byrne CP (2010) Life in the gut: microbial responses to stress in the gastrointestinal tract. Sci Prog 93(Pt 1):7–36
Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14(7):685–690
Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G et al (2015) Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis 21(6):1419–1427
Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20(2):159–166
Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ et al (2015) Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 6:7320
Brown EM, Sadarangani M, Finlay BB (2013) The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 14(7):660–667
Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148(6):1258–1270
Galley JD, Bailey MT (2014) Impact of stressor exposure on the interplay between commensal microbiota and host inflammation. Gut Microbes 5(3):390–396
Peterson CT, Sharma V, Elmén L, Peterson SN (2015) Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol 179(3):363–377
Chassaing B, Gewirtz AT (2014) Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 42(1):49–53
Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470–1481
Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld J-C et al (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453(7191):106–109
Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374):538–541
Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S et al (2009) Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol Baltim Md 1950 183(10):6041–50
Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL et al (2010) A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 3(5):487–495
Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S et al (2010) Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol Baltim Md 1950 185(7):4101–4108
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498
Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M et al (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature 455(7214):808–812
Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12(8):453–466
Riccio P, Rossano R (2015) Nutrition facts in multiple sclerosis. ASN Neuro 7(1)
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107(33):14691–14696
Nguyen NT, Nakahama T, Le DH, Van Son L, Chu HH, Kishimoto T (2014) Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol 5:551
Veldhoen M, Brucklacher-Waldert V (2012) Dietary influences on intestinal immunity. Nat Rev Immunol 12(10):696–708
Benson JM, Shepherd DM (2011) Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells. Toxicol Sci Off J Soc Toxicol 124(2):327–338
Bakdash G, Vogelpoel LTC, van Capel TMM, Kapsenberg ML, de Jong EC (2015) Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells. Mucosal Immunol 8(2):265–278
Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q et al (2014) Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 111(33):E3432–E3440
Hedström AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler J 18(9):1334–1336
Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85–97
Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D et al (2009) Obesity predisposes to Th17 bias. Eur J Immunol 39(9):2629–2635
Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901
La Cava A, Matarese G (2004) The weight of leptin in immunity. Nat Rev Immunol 4(5):371–379
Yu Y, Liu Y, Shi F-D, Zou H, Matarese G, La Cava A (2013) Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol Baltim Md 1950 190(7):3054–3058
Frisullo G, Mirabella M, Angelucci F, Caggiula M, Morosetti R, Sancricca C et al (2007) The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 192(1–2):174–183
Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8(5):500–508
Swank RL, Goodwin JW (2003) How saturated fats may be a causative factor in multiple sclerosis and other diseases. Nutr Burbank Los Angel Cty Calif 19(5):478
Swank RL (1950) Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci 220(4):421–430
Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C et al (2013) Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38(6):1154–1163
Sakata D, Yao C, Narumiya S (2010) Prostaglandin E2, an immunoactivator. J Pharmacol Sci 112(1):1–5
Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A et al (2015) Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43(4):817–829
Evans MA, Shronts EP (1992) Intestinal fuels: glutamine, short-chain fatty acids, and dietary fiber. J Am Diet Assoc 92(10):1239–46, 1249
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569–573
Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T et al (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One 10(9):e0137429
Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461):232–236
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331(6015):337–341
Säemann MD, Böhmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C et al (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J Off Publ Fed Am Soc Exp Biol 14(15):2380–2382
Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450
Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451–455
Wang L, de Zoeten EF, Greene MI, Hancock WW (2009) Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov 8(12):969–981
Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221–1227
Brown IJ, Tzoulaki I, Candeias V, Elliott P (2009) Salt intakes around the world: implications for public health. Int J Epidemiol 38(3):791–813
Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE et al (2014) Global sodium consumption and death from cardiovascular causes. N Engl J Med 371(7):624–634
D’Elia L, Galletti F, Strazzullo P (2014) Dietary salt intake and risk of gastric cancer. Cancer Treat Res 159:83–95
Sundström B, Johansson I, Rantapää-Dahlqvist S (2015) Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study. Rheumatol Oxf Engl 54(3):487–493
Farez MF, Fiol MP, Gaitán MI, Quintana FJ, Correale J (2015) Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 86(1):26–31
Hucke S, Wiendl H, Klotz L (2015) Implications of dietary salt intake for multiple sclerosis pathogenesis. Mult Scler Houndmills Basingstoke Engl
Go WY, Liu X, Roti MA, Liu F, Ho SN (2004) NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci USA 101(29):10673–10678
Shapiro L, Dinarello CA (1995) Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92(26):12230–12234
Woehrle T, Yip L, Manohar M, Sumi Y, Yao Y, Chen Y et al (2010) Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J Leukoc Biol 88(6):1181–1189
Müller S, Quast T, Schröder A, Hucke S, Klotz L, Jantsch J et al (2013) Salt-dependent chemotaxis of macrophages. PloS One 8(9):e73439
Zhang W-C, Zheng X-J, Du L-J, Sun J-Y, Shen Z-X, Shi C et al (2015) High salt primes a specific activation state of macrophages, M(Na). Cell Res 25(8):893–910
Jantsch J, Schatz V, Friedrich D, Schröder A, Kopp C, Siegert I et al (2015) Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab 21(3):493–501
Binger KJ, Gebhardt M, Heinig M, Rintisch C, Schroeder A, Neuhofer W et al (2015) High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest 125(11):4223–4238
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA et al (2013) Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496(7446):518–522
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y et al (2013) Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496(7446):513–517
Hernandez AL, Kitz A, Wu C, Lowther DE, Rodriguez DM, Vudattu N et al (2015) Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest 125(11):4212–4222
Zhou X, Zhang L, Ji W-J, Yuan F, Guo Z-Z, Pang B et al (2013) Variation in dietary salt intake induces coordinated dynamics of monocyte subsets and monocyte-platelet aggregates in humans: implications in end organ inflammation. PLoS One 8(4):e60332
Yi B, Titze J, Rykova M, Feuerecker M, Vassilieva G, Nichiporuk I et al (2015) Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: a longitudinal study. Transl Res J Lab Clin Med 166(1):103–110
Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Müller DN et al (2013) 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension 61(3):635–640
Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K et al (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15(5):545–552
Wiig H, Schröder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV et al (2013) Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 123(7):2803–2815
Linz P, Santoro D, Renz W, Rieger J, Ruehle A, Ruff J et al (2015) Skin sodium measured with 23Na MRI at 7.0 T. NMR Biomed 28(1):54–62
Ip WKE, Medzhitov R (2015) Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation. Nat Commun 6:6931
Krementsov DN, Case LK, Hickey WF, Teuscher C (2015) Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific. FASEB J Off Publ Fed Am Soc Exp Biol 29(8):3446–3457
